Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?

被引：25

作者：

Machiels, Julian D. ^{[1
,2
]}

Bleeker-Rovers, Chantal P. ^{[2
,3
]}

ter Heine, Rob ^{[2
,4
]}

Rahamat-Langendoen, Janette ^{[1
,2
]}

de Mast, Quirijn ^{[2
,3
]}

ten Oever, Jaap ^{[2
,3
]}

Bousema, Teun ^{[1
,2
]}

van Crevel, Reinout ^{[2
,3
]}

Wertheim, Heiman F. L. ^{[1
,2
]}

机构：

[1] Dept Med Microbiol, Nijmegen, Netherlands

[2] Radboudumc Ctr Infect Dis, Nijmegen, Netherlands

[3] Dept Internal Med, Nijmegen, Netherlands

[4] Dept Pharm, Nijmegen, Netherlands

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2020年 / 56卷 / 01期

关键词：

COVID-19; SARS-CoV-2; 2019-nCoV; (Hydroxy)chloroquine; Azithromycin; IN-VITRO; CHLOROQUINE; CORONAVIRUS; PHARMACOKINETICS; DISPOSITION; ENANTIOMERS; INHIBITION; VIRUS; DRUG;

D O I：

10.1016/j.ijantimicag.2020.106056

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The severity of COVID-19 has resulted in a global rush to find the right antiviral treatment to conquer the pandemic and to treat patients. This requires reliable studies to support treatment. In a recently published study by Gautret et al. the authors concluded that hydroxychloroquine monotherapy and hydroxychloroquine in combination with azithromycin reduced viral load. However, this trial has several major methodological issues, including the design, outcome measure and the statistical analyses. In this paper we discuss the background, clinical evidence, pharmacology and methodological issues related to this clinical trial. We understand the rush to release results, however in case conclusions are far reaching the evidence needs to be robust. (C) 2020 Elseier B.V. and International Society of Chemotherapy. All rights reserved.

引用

页数：4

共 54 条

[1] COVID-19: Disease, management, treatment, and social impact [J].

Ali, Imran ;

Alharbi, Omar M. L. .

SCIENCE OF THE TOTAL ENVIRONMENT, 2020, 728

[2] Macrolides in critically ill patients with Middle East Respiratory Syndrome [J].

Arabi, Yaseen M. ;

Deeb, Ahmad M. ;

Al-Hameed, Fahad ;

Mandourah, Yasser ;

Almekhlafi, Ghaleb A. ;

Sindi, Anees A. ;

Al-Omari, Awad ;

Shalhoub, Sarah ;

Mady, Ahmed ;

Alraddadi, Basem ;

Almotairi, Abdullah ;

Al Khatib, Kasim ;

Abdulmomen, Ahmed ;

Qushmaq, Ismael ;

Solaiman, Othman ;

Al-Aithan, Abdulsalam M. ;

Al-Raddadi, Rajaa ;

Ragab, Ahmad ;

Al Harthy, Abdulrahman ;

Kharaba, Ayman ;

Jose, Jesna ;

Dabbagh, Tarek ;

Fowler, Robert A. ;

Balkhy, Hanan H. ;

Merson, Laura ;

Hayden, Frederick G. .

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 81 :184-190

[3]

Borba M, 2020, CHLOROQUINE DIPHOSPH

[4] A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 [J].

Boulware, David R. ;

Pullen, Matthew F. ;

Bangdiwala, Ananta S. ;

Pastick, Katelyn A. ;

Lofgren, Sarah M. ;

Okafor, Elizabeth C. ;

Skipper, Caleb P. ;

Nascene, Alanna A. ;

Nicol, Melanie R. ;

Abassi, Mahsa ;

Engen, Nicole W. ;

Cheng, Matthew P. ;

LaBar, Derek ;

Lother, Sylvain A. ;

MacKenzie, Lauren J. ;

Drobot, Glen ;

Marten, Nicole ;

Zarychanski, Ryan ;

Kelly, Lauren E. ;

Schwartz, Ilan S. ;

McDonald, Emily G. ;

Rajasingham, Radha ;

Lee, Todd C. ;

Hullsiek, Kathy H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (06) :517-525

[5]

Browning DJ, 2014, HYDROXY CHLOROQUINE

[6]

Chen Z, Multiscale Modeling Simulation

[7] The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin [J].

Chorin, Ehud ;

Dai, Matthew ;

Shulman, Eric ;

Wadhwani, Lalit ;

Bar-Cohen, Roi ;

Barbhaiya, Chirag ;

Aizer, Anthony ;

Holmes, Douglas ;

Bernstein, Scott ;

Spinelli, Michael ;

Park, David S. ;

Chinitz, Larry A. ;

Jankelson, Lior .

NATURE MEDICINE, 2020, 26 (06) :808-809

[8] ENANTIOSELECTIVE DISPOSITION OF HYDROXYCHLOROQUINE AFTER A SINGLE ORAL DOSE OF THE RACEMATE TO HEALTHY-SUBJECTS [J].

DUCHARME, J ;

FIEGER, H ;

DUCHARME, MP ;

KHALIL, SKW ;

WAINER, IW .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 40 (02) :127-133

[9] Connecting Hydroxychloroquine In Vitro Antiviral Activity to In Vivo Concentration for Prediction of Antiviral Effect: A Critical Step in Treating Patients With Coronavirus Disease 2019 [J].

Fan, Jianghong ;

Zhang, Xinyuan ;

Liu, Jiang ;

Yang, Yuching ;

Zheng, Nan ;

Liu, Qi ;

Bergman, Kimberly ;

Reynolds, Kellie ;

Huang, Shiew-Mei ;

Zhu, Hao ;

Wang, Yaning .

CLINICAL INFECTIOUS DISEASES, 2020, 71 (12) :3232-3236

[10] Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection [J].

Fantini, Jacques ;

Di Scala, Coralie ;

Chahinian, Henri ;

Yahi, Nouara .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (05)

← 1 2 3 4 5 6 →